Forrester Announces The APAC Recipients Of Its 2025 Technology Awards
SINGAPORE, Aug. 4, 2025 /PRNewswire/ -- Forrester (Nasdaq: FORR) today announced that FWD Group and YCH Group are the winners of its 2025 Technology Strategy Impact Award for Asia Pacific and that The Hong Kong Jockey Club is the APAC winner of its Enterprise Architecture (EA) Award. These awards, which will be presented at Technology & Innovation Summit APAC, taking place in Sydney, Australia, and digitally, on August 19, 2025, will recognize these organizations for aligning their technology strategies to accelerate business outcomes.
"This year's Technology Award winners exemplify how aligning tech strategy with business goals can drive measurable impact," said Frederic Giron, VP and senior research director at Forrester. "These organizations delivered trusted, secure, and resilient technology foundations that empower their organizations to adapt swiftly to market shifts and evolving customer needs. Their successes reflect a deep commitment to using technology as a catalyst for innovation, growth, and long-term value. We look forward to hearing their success stories at Technology & Innovation Summit APAC."
Information about Forrester's 2025 Technology Strategy Impact Award winners and runner-up:
Information about Forrester's 2025 Enterprise Architecture Award winner and runners-up, presented in partnership with The Open Group:
About Forrester
Forrester (Nasdaq: FORR) is one of the most influential research and advisory firms in the world. We empower leaders in technology, customer experience, digital, marketing, sales, and product functions to be bold at work and accelerate growth through customer obsession. Our unique research and continuous guidance model helps executives and their teams achieve their initiatives and outcomes faster and with confidence. To learn more, visit Forrester.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Korea Herald
3 days ago
- Korea Herald
Seoul shares open slightly higher on US gains
South Korean stocks started slightly higher Thursday, tracking overnight gains on Wall Street on growing hopes for the Federal Reserve's monetary easing. The benchmark Korea Composite Stock Price Index rose 8.14 points, or 0.25 percent, to 3,232.51 in the first 15 minutes of trading. In the United States, the benchmark S&P 500 and Nasdaq indexes climbed to new highs Wednesday on the previous day's mild inflation data and the government's repeated calls for a rate cut. The S&P 500 gained 0.32 percent and the Nasdaq Composite rose 0.14 percent to close at new all-time highs. The Dow Jones Industrial Average also added 1.04 percent. In Seoul, battery and auto shares led the early gains. Leading battery maker LG Energy Solution advanced 1.67 percent, and POSCO Future M increased 1.38 percent. Top carmaker Hyundai Motor mounted 0.93 percent, and its auto parts affiliate Hyundai Mobis climbed 0.33 percent. Defense giant Hanwha Aerospace rose 1.37 percent following a US$250 million deal to export its homegrown K9 self-propelled howitzers to Vietnam. However, top-cap Samsung Electronics fell 0.63 percent. The local currency was trading at 1,380.1 won against the US dollar at 9:15 a.m., up 1.6 won from the previous session. (Yonhap)
Korea Herald
4 days ago
- Korea Herald
HLB appoints Brian Kim as CEO of US subsidary Elevar Therapeutics
Korean biopharmaceutical firm HLB said Wednesday it has appointed Brian Kim, current CEO of HLB Innovation and Verismo Therapeutics, as CEO of its US subsidiary, Elevar Therapeutics. Kim will lead all three companies concurrently. HLB said the leadership change is a strategic move to align with the skills needed at each stage of drug development, particularly as Elevar prepares to enter the commercialization phase and expand global partnerships with big pharma. Kim holds extensive experience in finance, strategic business management and biotechnology, including research in CAR-T cancer treatments and founding multiple biotech firms. A former tenured clinical professor at the University of Pennsylvania School of Dental Medicine, Kim was a founding member of Nasdaq-listed Inovio Pharmaceuticals. He has invested in various businesses, including acquiring a Kospi-listed company and elevating it into the Kospi 200 index. Kim also has invested in and led several biotech ventures in both the US and Korea. 'I feel a deep sense of responsibility taking on this role at such a pivotal moment,' Kim said. 'My focus will be on securing regulatory approval for Elevar's lead liver cancer therapy and ensuring its successful commercialization, while driving sustainable growth for the company.' HLB added that Kim's leadership will help accelerate Elevar's global business expansion and innovation in oncology therapeutics.
Korea Herald
4 days ago
- Korea Herald
Seoul shares start higher on US gains
South Korean stocks opened higher Wednesday, tracking overnight gains on Wall Street driven by rate cut hopes. The benchmark Korea Composite Stock Price Index rose 25.68 points, or 0.81 percent, to 3,215.59 in the first 15 minutes of trading. US stocks finished higher on the better-than-expected consumer prices report, sparking hopes that the Federal Reserve may cut its key rate at its next meeting in September. The Dow Jones Industrial Average rose 1.1 percent, and the Nasdaq composite advanced 1.39 percent. In Seoul, most shares started in positive territory. Market bellwether Samsung Electronics rose 0.84 percent, and chip giant SK hynix jumped 2.42 percent. Top carmaker Hyundai Motor gained 1.17 percent, and major shipbuilder HD Korea Shipbuilding & Offshore Engineering vaulted 7.02 percent. Samyang Foods, an instant noodle maker well known for its global hit Buldak ramyeon, increased 0.21 percent, and national flag carrier Korean Air climbed 3.14 percent. The local currency was trading at 1,383.95 won against the greenback at 9:15 a.m., up 5.95 won from the previous session. (Yonhap)
